HCA Healthcare, Inc.

HCA Healthcare, Inc.

HCA·NYSE

$363.23

-2.1%
HealthcareMedical - Care Facilities

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

At a Glance

Live Snapshot
Market Cap$80.58B
EPS28.6200
P/E Ratio12.69
Earnings Date07/24/2026
18.53%
Return on Invested Capital
11%
3Y+11.0%
5Y+24.0%
10Y+18.0%
-112.56%
Return on Equity
-51%
3Y-45.0%
5Y-117.0%
10Y+184.0%
11.17%
Return on Assets
15%
3Y+4.0%
5Y+41.0%
10Y+31.0%
HCA Healthcare, Inc.

HCA Healthcare, Inc. Management Team

HCA · NYSE
MS

Mr. Samuel N. Hazen

Chief Executive Officer & Director

Compensation

$6,846,331

Born 1960(Age 66)
male
MM

Mr. Michael A. Marks

Chief Financial Officer & Executive Vice President

Compensation

$2,381,758

Born 1970(Age 56)
male
DM

Dr. Michael S. Cuffe M.B.A., M.D.

Executive Vice President & Chief Clinical Officer

Compensation

$2,911,023

Born 1966(Age 60)
MJ

Mr. Jon Mack Foster

Executive Vice President & Chief Operating Officer

Compensation

$3,555,267

Born 1962(Age 64)
male
MM

Mr. Michael R. McAlevey

Executive Vice President and Chief Legal & Administrative Officer

Compensation

$2,955,500

Born 1964(Age 62)
male
DT

Dr. Thomas F. Frist Jr., M.D.

Founder & Chairman Emeritus

Compensation

$17,973

Born 1939(Age 87)
MC

Mr. Chad J. Wasserman

Senior Vice President & Chief Information Officer

male
MW

Ms. Wendy Warren

Senior Vice President, Chief Ethics & Compliance Officer

female
MC

Mr. Christopher F. Wyatt

Senior Vice President, Principal Accounting Officer & Controller

Born 1978(Age 48)
male
MF

Mr. Frank George Morgan C.F.A.

Vice President of Investor Relations

male
hca

HCA Healthcare, Inc. Insider Positioning

HCA · NYSE

During the last 12 months, insiders have sold $16.54M worth of HCA shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

25.9K

13.09M

Net Activity

-13.1M

-$13.09M

6-9 Months

Bought

0

0.00

Sold

7.7K

3.45M

Net Activity

-3.5M

-$3.45M

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
HSN

Hazen Samuel N

Director, Officer: Ceo

14.7K shares1 transactions

$7.40M

2
MMR

Mcalevey Michael R

Officer: Evp & Chief Legal & Admin Off.

5.6K shares2 transactions

$2.75M

3
CMS

Cuffe Michael S.

Officer: Evp And Chief Clinical Officer

5.3K shares2 transactions

$2.35M

4
WCF

Wyatt Christopher F.

Officer: Svp & Controller

4.0K shares1 transactions

$2.02M

5
BJ

Berres Jennifer

Officer: Svp & Chief Human Res. Officer

4.0K shares1 transactions

$2.02M

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $16.54M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

SEC Filings

HCA - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

March 13, 2026
April 23, 2026
2026
DEF 14A

DEF 14A 2025

N/A

March 14, 2025
April 24, 2025
2025
DEF 14A

DEF 14A 2024

N/A

March 15, 2024
April 25, 2024
2024
DEF 14A

DEF 14A

N/A

March 10, 2023
March 10, 2023
 
DEF 14A

DEF 14A 2022

N/A

March 11, 2022
April 21, 2022
2022
DEF 14A

DEF 14A 2021

N/A

March 19, 2021
April 28, 2021
2021
DEF 14A

DEF 14A 2020

N/A

March 20, 2020
May 01, 2020
2020
DEF 14A

DEF 14A 2019

N/A

March 15, 2019
April 26, 2019
2019
DEF 14A

DEF 14A 2018

N/A

March 16, 2018
April 26, 2018
2018
DEF 14A

DEF 14A 2017

N/A

March 17, 2017
April 27, 2017
2017
Showing 1 to 10 of 28 filings